insights_auto
Why is CMXHF up २.२२%?
Dive Deeperchevron_right
CMXHF:OTCMKTS
CSL Ltd
US$ १२३.७९
arrow_upward
+२.२२%(+२.६९) 1D
अक्टोबर १५, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Open
US$ १२९.२२
High
US$ १२९.२२
Low
US$ १२३.७९
Mkt. cap
९२.२३ अरब
Avg. vol.
१६७.००
Volume
५६४.००
52-wk high
US$ १४८.३६
52-wk low
US$ ६३.८४
Beta
०.५६
Shares outstanding
४७.९९ करोड
No. of employees
२९ हजार
Open
US$ १२९.२२
High
US$ १२९.२२
Low
US$ १२३.७९
Mkt. cap
९२.२३ अरब
Avg. vol.
१६७.००
Volume
५६४.००
52-wk high
US$ १४८.३६
52-wk low
US$ ६३.८४
Beta
०.५६
Shares outstanding
४७.९९ करोड
No. of employees
२९ हजार
News stories
From web sources and news partners
TheBull.com.au
·
१ दिन पहिले
CSL Shares Double Off Lows: How Do They Stack Up Against TLX, SIG?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees२९ हजार
Founded१९१६
Headquartersमेलबर्न, भिक्टोरिया, अष्ट्रेलिया
Sector-
Websitecsl.com